Evidence map›Paper›PMID 40901394›Full record

ArticlePreventive nutrition and food science2025

Two Optimized Cysteine Protease-Aided Protein Hydrolysates of Soybean Tempeh Inhibit Angiotensin-Converting Enzyme Activity

Sukrasno Sukrasno, Defri Rizaldy, Neng Fisheri Kurniati, Cut Raihanah, Arif Al Iman

Abstract read
In one paragraph

Article in Preventive nutrition and food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sukrasno SukrasnoDepartment of Pharmaceutical Biology, School of Pharmacy, Bandung Institute of Technology, West Java 40132, Indonesia.ORCID https://orcid.org/0000-0002-9303-0852
Defri RizaldyDepartment of Pharmaceutical Biology, School of Pharmacy, Bandung Institute of Technology, West Java 40132, Indonesia.ORCID https://orcid.org/0000-0001-9745-3855
Neng Fisheri KurniatiDepartment of Pharmacology - Clinical Pharmacy, School of Pharmacy, Bandung Institute of Technology, West Java 40132, Indonesia.ORCID https://orcid.org/0000-0002-3313-6612
Cut RaihanahDepartment of Pharmaceutical Biology, School of Pharmacy, Bandung Institute of Technology, West Java 40132, Indonesia.ORCID https://orcid.org/0000-0002-4858-8523
Arif Al ImanDepartment of Pharmaceutical Biology, School of Pharmacy, Bandung Institute of Technology, West Java 40132, Indonesia.ORCID https://orcid.org/0009-0004-1583-5593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptides produced from soybean tempeh that inhibit angiotensin-converting enzyme (ACE) provide a promising source of novel antihypertensive agents. This study utilized two cysteine proteases (papain and bromelain) to generate ACE inhibitory peptides from the protein hydrolysate of soybean tempeh. The trials were arranged using a Box-Behnken design to achieve optimal hydrolysis conditions. The optimal conditions, which were determined by response surface methodology optimization, were as follows: papain: pH 9, temperature 62.88°C, enzyme/substrate ratio 0.54%, and hydrolysis duration 14.94 h; bromelain: pH 9, temperature 60°C, enzyme/substrate ratio 1%, and hydrolysis duration 1 h. According to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and liquid chromatography tandem mass spectrometry analysis, the protein hydrolysates displayed peptide bands within the 23-30 kDa range, comprising various peptides from monopeptides to nonapeptides. Moreover, these protein hydrolysates exhibited a more pronounced ACE inhibition than the crude protein extract, with the lowest IC

Indexed as

angiotensin converting enzymecysteine proteasesprotein hydrolysatessoybeanstempeh

Identifiers

PMID40901394
PMCPMC12399911

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.